Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Charles Clough (Clough Capital Partners): Holdings and New Stock Picks

Insider Monkey, your source for free insider trading data, published an article about Charles Clough’s top holdings and new stock picks. Here is an excerpt from the article:

Clough’s largest new stock picks have gained 5.6% since the end of 2010, vs. 4.0% gain for the S&P 500 (SPY). LCAPA has had one of the best performances in his portfolio since the end of December.

Bill Miller

Clough had $14.3 million in LCAPA shares at the end of December. LCAPA has gained 16.7% in the last 75 days, beating the SPY by 12.7 percentage points. Tiger Global’s Chase Coleman, Daniel Loeb’s Third Point and Whitney Tilson’s T2 Partners are other investors of LCAPA as the end of December. IBM was Clough’s biggest new investment at the end of December 2010. IBM has gained 11.1% since then, outperforming the SPY’s 4.0% return. Clough has $55.6 million invested in IBM. Bill Miller also had $283 million invested in IBM. The worst performing stock among the new purchases was Weatherford International, losing 9.1% since the end of December. T. Boone Pickens and Barry Rosenstein’s Jana Partners have WFT in their portfolios.

Clough uses put options on index funds extensively to protect his portfolio from market declines. That’s why the biggest position in his portfolio is a put option on S&P 500 Index fund with a notional value of $2.06 Billion. He also has put options on First Trust NASDAQ-100 Ex-Techn (QQXT) and Oil Services Holders (OIH) totaling more than $400 Million.

Read the entire article at Seeking Alpha>>>

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!